Skip to main content

Advertisement

SpringerLink
Log in

Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Cervical lymph node metastases reduce the overall survival of patients with oral squamous cell carcinoma (OSCC) and require a neck dissection. However, elective management of a clinical N0 neck remains a controversial topic, as there are no reliable factors available predicting cervical lymph node metastases. Recent studies suggest an impact of podoplanin expression on metastatic spread to the cervical lymph nodes. Our aim was to investigate the influence of podoplanin expression on prognosis and metastatic lymphatic spread. In our retrospective study, podoplanin expression was examined in a set of 80 patients with OSCC by immunhistochemistry. We analysed associations between the level of podoplanin expression and various clinicopathologic parameters. In 67 patients (84%), podoplanin was expressed on the tumour cells. Nineteen patients (24%) showed high levels of expression. The 5-year overall survival (31%) for patients with high levels of podoplanin expression was significantly lower (p < 0.001) than for patients with low and moderate expression of podoplanin (93% and 65%, respectively). There was an association between podoplanin expression and the frequency of cervical lymph node metastases. Cervical lymph node metastases were found in 79% of the patients with high podoplanin expression, while patients with weak podoplanin expression had metastases in only 22% (p < 0.001). None of the 13 patients without podoplanin expression had cervical lymph node metastases. We concluded that podoplanin is expressed frequently in OSCC and that podoplanin expression correlates with cervical lymph node metastases and clinical outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Vormittag L, Thurnher D, Geleff S et al (2009) Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy. Int J Radiat Oncol Biol Phys 73:913–918

    CAS  PubMed  Google Scholar 

  2. Shah JP, Gil Z (2008) Current concepts in management of oral cancer—surgery. Oral Oncol 45:394–401

    Article  PubMed  Google Scholar 

  3. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249

    Article  PubMed  Google Scholar 

  4. Bernier J, Domenge C, Ozsahin M et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952

    Article  CAS  PubMed  Google Scholar 

  5. Neville BW, Day TA (2002) Oral cancer and precancerous lesions. CA Cancer J Clin 52:195–215

    Article  PubMed  Google Scholar 

  6. Eich HT, Löschke M, Scheer M et al (2008) Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients. Strahlenther Onkol 184:23–29

    Article  PubMed  Google Scholar 

  7. Klug C, Wutzl A, Kermer C et al (2005) Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor. Int J Oral Maxillofac Surg 34:262–267

    Article  CAS  PubMed  Google Scholar 

  8. Martin-Villar E, Scholl F, Gamallo C et al (2005) Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer 113:899–910

    Article  CAS  PubMed  Google Scholar 

  9. Patel V, Leethanakul C, Gutkind J (2001) New approaches to the understanding of the molecular basis of oral cancer. Crit Rev Oral Biol Med 12:55–63

    Article  CAS  PubMed  Google Scholar 

  10. Nagpal J, Das B (2003) Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol 39:213–221

    Article  CAS  PubMed  Google Scholar 

  11. Shah N, Trivedi T, Tankshali R et al (2009) Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck 31:1544–1556

    Article  PubMed  Google Scholar 

  12. Greenberg J, El Naggar K, Mo V et al (2003) Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implications for therapeutic decision making. Cancer 98:508–515

    Article  PubMed  Google Scholar 

  13. Shaw J, Lowe D, Woolgar J et al (2009) Extracapsular spread in oral squamous cell carcinoma. Head Neck (in press)

  14. Shingaki S, Takada M, Sasai K et al (2003) Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 185:278–284

    Article  PubMed  Google Scholar 

  15. Woolgar J, Hall G (2009) Determinants of outcome following surgery for oral squamous cell carcinoma. Future Oncol 5:51–61

    Article  PubMed  Google Scholar 

  16. Iype E, Sebastian P, Mathew A et al (2008) The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer. Oral Oncol 44:1134–1138

    Article  PubMed  Google Scholar 

  17. Arduino PG, Carrozzo M, Chiecchio A et al (2008) Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J Oral Maxillofac Surg 66:1570–1579

    Article  PubMed  Google Scholar 

  18. Scheer M, Kübler AC, Manawi NN et al (2005) Endosonographic imaging of tumor thickness in oral squamous cell cancer and its effect on the incidence of lymph node metastases. Mund Kiefer GesichtsChir 9:282–289

    Article  CAS  PubMed  Google Scholar 

  19. Yuen A, Ng R, Lam P, Ho A (2008) Preoperative measurement of tumor thickness of oral tongue carcinoma with intraoral ultrasonography. Head Neck 30:230–234

    Article  PubMed  Google Scholar 

  20. Franchi A, Gallo O, Massi D et al (2004) Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer 101:973–978

    Article  PubMed  Google Scholar 

  21. Miyahara M, Tanuma J, Sugihara K, Semba I et al (2007) Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 110:1287–1294

    Article  PubMed  Google Scholar 

  22. Sedivy R, Beck-Mannagetta J, Haverkampf C et al (2003) Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med 32:455–460

    Article  CAS  PubMed  Google Scholar 

  23. Yuan P, Temam S, El-Naggar A et al (2006) Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 107:563–569

    Article  CAS  PubMed  Google Scholar 

  24. Wang L, Liu T, Wang Y et al (2007) Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation. Virchows Arch 451:959–966

    Article  CAS  PubMed  Google Scholar 

  25. Raica M, Cimpean A, Ribatti D (2008) The role of podoplanin in tumor progression and metastasis. Anticancer Res 28:2997–3006

    PubMed  Google Scholar 

  26. Völker H, Scheich M, Nowack I et al (2009) Lymphangiosis carcinomatosa in squamous cell carcinomas of larynx and hypopharynx—value of conventional evaluation and additional immunohistochemical staining of D2–40. World J Surg Oncol 7:25

    Article  PubMed  Google Scholar 

  27. Kahn H, Marks A (2002) A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255–1257

    PubMed  Google Scholar 

  28. Schacht V, Dadras S, Johnson L et al (2005) Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166:913–921

    CAS  PubMed  Google Scholar 

  29. Breitender-Geleff S, Soleiman A, Kowalski H et al (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385–394

    Google Scholar 

  30. Kawaguchi H, El-Naggar A, Papadimitrakopoulou V et al (2008) Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol 26:354–360

    Article  PubMed  Google Scholar 

  31. Durchdewald M, Guinea-Viniegra J, Haag D et al (2008) Podoplanin is a novel fos target gene in skin carcinogenesis. Cancer Res 68:6877–6883

    Article  CAS  PubMed  Google Scholar 

  32. Shimada Y, Ishii G, Atsumi N et al (2009) Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung. Cancer Sci 100:2054–2059

    Article  CAS  PubMed  Google Scholar 

  33. Dumoff K, Chu C, Harris E et al (2006) Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation. Mod Pathol 19:708–716

    Article  CAS  PubMed  Google Scholar 

  34. Liang P, Hong J, Ubukata H et al (2006) Increased density and diameter of lymphatic microvessels correlate with lymph node metastasis in early stage invasive colorectal carcinoma. Virchows Arch 448:470–475

    Article  Google Scholar 

  35. Chuang W, Yeh C, Wu Y et al (2009) Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma. Histol Histopathol 24:1021–1027

    CAS  PubMed  Google Scholar 

  36. Rahadiani N, Ikeda J, Makino T et al (2010) Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma. Ann Surg Oncol. doi:10.1245/s10434-009-0895-5

  37. Padgett D, Cathro H, Wick M, Mills S (2008) Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin. Am J Surg Pathol 32:123–127

    Article  PubMed  Google Scholar 

  38. Mishima K, Kato Y, Kaneko M et al (2006) Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression. Acta Neuropathol 115:483–488

    Article  Google Scholar 

  39. Shibahara J, Kashima T, Kikuchi Y et al (2006) Podoplanin is expressed in subsets of tumors of the central nervous system. Virchows Arch 448:493–499

    Article  CAS  PubMed  Google Scholar 

  40. Erovic B, Neuchrist C, Kandutsch S et al (2003) CD9 expression on lymphatic vessels in head and neck mucosa. Mod Pathol 16:1028–1034

    Article  PubMed  Google Scholar 

  41. Ji R (2006) Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: new insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev 25:677–694

    Article  PubMed  Google Scholar 

  42. Wicki A, Lehembre F, Wick N et al (2006) Tumor invasion in the absence of epithelial–mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9:261–272

    Article  CAS  PubMed  Google Scholar 

  43. Ferlito A, Silver C, Rinaldo A (2009) Elective management of the neck in oral cavity squamous carcinoma: current concepts supported by prospective studies. Br J Oral Maxillofac Surg 47:5–9

    Article  PubMed  Google Scholar 

  44. Yuen A, Ho C, Chow T et al (2009) Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck 31:765–772

    Article  PubMed  Google Scholar 

  45. D’Cruz A, Siddachari R, Walvekar R et al (2009) Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: need for a randomized controlled trial. Head Neck 31:618–624

    Article  PubMed  Google Scholar 

  46. O’Sullivan B, Shap J (2003) New TNM staging criteria for head and neck tumors. Semin Surg Oncol 21:30–42

    Article  PubMed  Google Scholar 

  47. Bhalang K, Kafrawy A, Miles D (1999) Immunohistochemical study of the expression of human chorionic gonadotropin-beta in oral squamous cell carcinoma. Cancer 85:757–762

    Article  CAS  PubMed  Google Scholar 

  48. Renkonen J, Wolff H, Paavonen T (2002) Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions. Virchows Arch 440:594–587

    Article  CAS  PubMed  Google Scholar 

  49. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Statist Assoc 53:457–481

    Article  Google Scholar 

  50. Cox D (1972) Regression modell and life-tables. J R Stat Soc 34:187–220

    Google Scholar 

  51. Atsumi N, Ishii G, Kojima M et al (2008) Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431. Biochem Biophys Res Commun 373:31–36

    Article  Google Scholar 

  52. Chung M, Min J, So Y et al (2009) Correlation between lymphatic vessel density and regional metastasis in squamous cell carcinoma of the tongue. Head Neck epub ahead of print

  53. Longatto-Filho A, Oliveira T, Pinheiro C et al (2007) How useful is the assessment of lymphatic vascular density in oral carcinoma prognosis? World J Surg Oncol 5:140

    Article  PubMed  Google Scholar 

  54. Kyzas P, Geleff S, Batistatou A et al (2005) Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 206:170–177

    Article  PubMed  Google Scholar 

  55. Capote A, Escorial V, Muòoz-Guerram M et al (2007) Elective neck dissection in early-stage oral squamous cell carcinoma–does it influence recurrence and survival? Head Neck 29:3–11

    Article  PubMed  Google Scholar 

  56. Madan R, Brandwein-Gensler M, Schlecht N et al (2006) Differential tissue and subcellular expression of ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma. Head Neck 28:1018–1027

    Article  PubMed  Google Scholar 

  57. Martin-Villar E, Megias D, Castel S et al (2006) Podoplanin binds ERM proteins to activate RhoA and promote epithelial–mesenchymal transition. J Cell Sci 119:4541–4553

    Article  CAS  PubMed  Google Scholar 

  58. Fan K, Lin C, Kang C et al (2007) Combined-modality treatment for advanced oral tongue squamous cell carcinoma. Int J Radiat Oncol Biol Phys 67:453–461

    PubMed  Google Scholar 

  59. Bernier J (2009) Current state-of-the-art for concurrent chemoradiation. Semin Radiat Oncol 19:3–10

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no potential or actual conflict of interest.

Author information

Authors and Affiliations

  1. Department for Oral and Cranio-maxillo and Facial Plastic Surgery, University of Cologne, Kerpener Strasse 62, 50931, Cologne, Germany

    Matthias Kreppel, Martin Scheer, Lutz Ritter & Joachim E. Zöller

  2. Department of Pathology, University of Cologne, Cologne, Germany

    Uta Drebber

  3. Centre of Integrated Oncology (CIO) Cologne-Bonn, Cologne, Germany

    Matthias Kreppel, Martin Scheer, Uta Drebber, Lutz Ritter & Joachim E. Zöller

Authors
  1. Matthias Kreppel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Scheer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Uta Drebber
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lutz Ritter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joachim E. Zöller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthias Kreppel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kreppel, M., Scheer, M., Drebber, U. et al. Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations. Virchows Arch 456, 473–482 (2010). https://doi.org/10.1007/s00428-010-0915-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-010-0915-7

Keywords

Search

Navigation